Why read a 1986 review?

It records what the field expected next, which can be compared against what actually followed — a direct measure of how the programme went.

Was the field aware of the immunoassay problem?

Yes. Graf co-authored the 1984 work showing peripheral immunoreactive material was mostly larger than DSIP.

A receptor and a gene. Without a receptor there is no way to attribute an observed effect to a pathway.

DSIP (Delta Sleep-Inducing Peptide)

What the Field Said After Its First Decade

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-232 cited sources

Graf published an update on delta sleep-inducing peptide in Peptides in 1986, nine years after the original report. Reviews written mid-literature are useful precisely because they record what the field expected next.

Key facts

Review: Graf 1986 (PMID 3550726)
Journal: Peptides, Nov–Dec 1986
Years after discovery: Nine
Author: Also co-author of the 1984 tissue work
Value of mid-literature reviews: They record expectations
What followed: No gene, no receptor

Why a nine-year update is a useful document

A review written at the point where a field still expects resolution captures something later accounts cannot. It records what was thought to be nearly settled and what was expected imminently. Comparing that against what actually followed is a direct measure of how a research programme went.

Where the field stood at that point

The sequence was known, synthesis was routine, immunoassays existed, and distribution had been mapped across brain and peripheral tissue. That is a substantial platform, and by the ordinary progression it should have been followed by receptor identification and then a gene. Neither arrived.

Research material referenced

DSIP 5mg — third-party HPLC tested

View — £13.99

What the same author had already reported

Graf was a co-author of the 1984 work showing that peripheral immunoreactive material was mostly larger than DSIP. So the complication was known to the person writing the update — this was not a field unaware of its own difficulties, which is worth stating plainly given how often the sceptical case is presented as hindsight.

Why the receptor never arriving is decisive

A receptor gives a field binding assays, dose-response relationships, selective antagonists and a target. Without one, an observed effect cannot be attributed to a pathway, and forty further years of work has not supplied it. This site makes the same point about MOTS-c, Selank and Semax, and DSIP is the longest-running instance.

How to read old reviews generally

As evidence about the state of a field at a date, not as current summaries. A 1986 review is accurate about 1986. Citing it as though it described the present position, which happens with compounds whose literature peaked decades ago, misrepresents both the review and the field.

Regulatory position

DSIP holds no marketing authorisation anywhere, and no claim is made here about sleep or any condition in any person. Material supplied is for laboratory research only.

Extended research context

The DSIP (Delta Sleep-Inducing Peptide) deep dive

Deep dive: a name that was a hypothesis, not a finding

In 1977 the Schoenenberger-Monnier group in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, isolated a peptide fraction, and reported that administering it into the ventricles of awake rabbits produced delta-wave EEG activity. They named it delta sleep-inducing peptide. By the standards of the time this was careful, imaginative work, and they followed it properly - the 1978 Pflugers Archiv paper reported sequence, synthesis and activity of the synthetic nonapeptide rather than stopping at a suggestive fraction. The problem is not the original research. It is that a name recording a hypothesis has been read ever since as a summary of established pharmacology, and almost nobody checks whether it was earned.

Deep dive: the three things that are missing

A proposed endogenous peptide becomes accepted biology by a recognisable route. The gene is located. The precursor protein is characterised. A receptor is identified, giving a mechanism and a testable target. DSIP has completed none of these in nearly fifty years. The receptor gap is the most disabling - without one there is no mechanism to test, no dose-response to build, no antagonist to design, and no way to establish that an observed effect runs through the proposed pathway at all. The gene gap is the hardest to explain away: modern genomics located MOTS-c inside a short open reading frame nested within the mitochondrial 12S rRNA gene, sequence already annotated as something else. That a peptide described in 1977 still has no identified gene in any genome is a substantive observation, not an accident of effort.

Deep dive: why 519 papers is not 519 confirmations

DSIP has roughly 519 indexed PubMed records - more than Selank's 135 or Semax's 231. Publication volume tracks how interesting a question is, not how well it has been answered. A tractable question generates a burst of work and then stops; a question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. Kovalzon's 2006 review in the Journal of Neurochemistry states the field's own assessment in its title: a still unresolved riddle. Reading any individual DSIP paper without that context invites mistaking activity for consensus.

Research applications

▸Historical study of humoral sleep-factor hypotheses
▸Electroencephalography and delta-wave research methodology
▸Structure-activity work on flexible, acidic short peptides
▸Comparative work on peptides lacking identified receptors
▸Analytical method development for tryptophan-containing peptides

Handling checklist

✓Store lyophilised material cold, dry and protected from light
✓No reducing agent needed — the sequence contains no cysteine
✓No methionine oxidation to expect; a +16 Da satellite warrants explanation
✓Protect from prolonged light — the single tryptophan is mildly photosensitive
✓Expect pH-dependent solubility; the peptide is strongly acidic with no basic residue
✓Aliquot to avoid repeated freeze-thaw cycles

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Treating the name as evidence of the effect

Fix: The name records a 1977 hypothesis from a single rabbit EEG study. It is not a summary of established pharmacology.

✗ Citing the 1977 paper as proof DSIP induces sleep

Fix: It reports delta-wave EEG activity in rabbits after intraventricular administration — a narrower claim than inducing sleep, in one species, by a route that bypasses every normal barrier.

✗ Assuming DSIP is an established endogenous human peptide

Fix: No gene has been identified in any species, no precursor characterised and no receptor found.

✗ Reading 519 papers as 519 confirmations

Fix: Volume reflects an unresolved question attracting sustained attempts, not accumulated confirmation.

✗ Making any sleep claim about supplied material

Fix: The evidence does not support it and a therapeutic claim about research material is what MHRA enforcement targets.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Why read a 1986 review?: It records what the field expected next, which can be compared against what actually followed — a direct measure of how the programme went.
Was the field aware of the immunoassay problem?: Yes. Graf co-authored the 1984 work showing peripheral immunoreactive material was mostly larger than DSIP.
What never arrived?: A receptor and a gene. Without a receptor there is no way to attribute an observed effect to a pathway.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More DSIP (Delta Sleep-Inducing Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum